This paper evaluates the potential impact of the Supreme Court’s upcoming decision on antibody patents and patent law’s enablement requirement on patient access to new drugs.This article was published in JAMA at https://jamanetwork.com/journals/jama/fullarticle/2803076

In a set of two studies , I determine: (1) which examiners are sending patents to litigation and, of those, (2) which examiners are sending invalidated patents to litigation. Together, these studies determine what conditions might predict the likelihood of an examiner’s patents getting...